QA: Cambrex CORP in us_pharma/2012

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000820081_2013_Cambrex_CORP.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0000820081, Cambrex CORP

  xvar xval
0 AssetsCurrent 143,970,000
1 IntangibleAssetsNetIncludingGoodwill 41,403,000
2 PropertyPlantAndEquipmentNet 151,815,000
3 remainder_Assets 57,280,000
4 LiabilitiesCurrent 83,026,000
5 LiabilitiesNoncurrent 74,195,000
6 remainder_Liabilities 73,950,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 45,248,000
9 ResearchAndDevelopmentExpense 9,544,000
10 remainder_Expenses 156,592,000
11 remainder_Revenues 276,501,000
12 remainder_NetIncome -2,814,000
13 remainder_ComprehensiveNetIncome -2,504,000
  yvar yval
0 Assets 394,468,000
1 Liabilities 231,171,000
2 Expenses 211,384,000
3 Revenues 276,501,000
4 StockholdersEquity 163,297,000
5 NetIncome 62,303,000
6 ComprehensiveNetIncome 61,051,000
7 BaseVar 559,421,000
8 EconomicCapitalRatiobeforeLimitedLiability 1.33
9 EconomicCapitalRatio 2.56

Edgar->Model Mapping

Feature Distribution

Change over Time